Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 56.69B | 55.85B | 52.10B | 48.04B | 44.03B | 43.13B |
Gross Profit | 29.60B | 24.49B | 22.68B | 20.61B | 36.04B | 30.07B |
EBITDA | 21.49B | 21.54B | 19.52B | 19.82B | 19.00B | 18.01B |
Net Income | 5.71B | 5.55B | 5.03B | 4.09B | 6.24B | 4.77B |
Balance Sheet | ||||||
Total Assets | 126.61B | 124.94B | 120.74B | 119.12B | 115.74B | 108.74B |
Cash, Cash Equivalents and Short-Term Investments | 8.19B | 6.69B | 4.36B | 2.27B | 6.45B | 5.76B |
Total Debt | 20.56B | 20.75B | 18.74B | 19.30B | 16.93B | 13.24B |
Total Liabilities | 58.46B | 55.14B | 51.11B | 50.67B | 45.66B | 39.18B |
Stockholders Equity | 68.07B | 69.73B | 69.57B | 68.40B | 70.01B | 69.56B |
Cash Flow | ||||||
Free Cash Flow | 10.30B | 10.55B | 9.97B | 9.05B | 8.78B | 11.05B |
Operating Cash Flow | 20.04B | 19.88B | 18.79B | 18.94B | 18.07B | 19.34B |
Investing Cash Flow | -9.39B | -8.91B | -7.85B | -14.20B | -8.13B | -6.41B |
Financing Cash Flow | -9.22B | -8.63B | -8.85B | -8.91B | -9.26B | -10.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $10.07B | 15.86 | 13.78% | 5.72% | -7.99% | 2.16% | |
74 Outperform | $18.99B | 13.28 | 17.71% | 6.69% | -5.13% | -5.90% | |
72 Outperform | $19.83B | 19.50 | 8.20% | 4.32% | -6.51% | -0.21% | |
68 Neutral | $59.76B | 20.64 | 14.41% | 2.67% | -0.64% | 56.92% | |
60 Neutral | $46.28B | 4.13 | -13.12% | 4.13% | 1.85% | -42.71% | |
60 Neutral | $28.34B | 9.21 | -7.17% | 4.21% | 0.89% | -494.16% | |
60 Neutral | $30.16B | ― | -3.55% | 6.74% | -4.73% | -251.31% |